312 related articles for article (PubMed ID: 11378162)
1. Signal transduction interactions between CB1 cannabinoid and dopamine receptors in the rat and monkey striatum.
Meschler JP; Howlett AC
Neuropharmacology; 2001 Jun; 40(7):918-26. PubMed ID: 11378162
[TBL] [Abstract][Full Text] [Related]
2. Dopamine receptor coupling to adenylyl cyclase in rat olfactory pathway: a combined pharmacological-radioautographic approach.
Coronas V; Krantic S; Jourdan F; Moyse E
Neuroscience; 1999 Apr; 90(1):69-78. PubMed ID: 10188934
[TBL] [Abstract][Full Text] [Related]
3. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
Dahmer MK; Senogles SE
J Neurochem; 1996 Jan; 66(1):222-32. PubMed ID: 8522958
[TBL] [Abstract][Full Text] [Related]
4. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
[TBL] [Abstract][Full Text] [Related]
5. Modulation by GTP of basal and agonist-stimulated striatal adenylate cyclase activity following chronic blockade of D1 and D2 dopamine receptors: involvement of G proteins in the development of receptor supersensitivity.
Schettini G; Ventra C; Florio T; Grimaldi M; Meucci O; Marino A
J Neurochem; 1992 Nov; 59(5):1667-74. PubMed ID: 1402912
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid receptor-regulated cyclic AMP accumulation in the rat striatum.
Bidaut-Russell M; Howlett AC
J Neurochem; 1991 Nov; 57(5):1769-73. PubMed ID: 1681035
[TBL] [Abstract][Full Text] [Related]
7. Dopamine-opioid interactions in the rat striatum: a modulatory role for dopamine D1 receptors in delta opioid receptor-mediated signal transduction.
Unterwald EM; Cuntapay M
Neuropharmacology; 2000 Jan; 39(3):372-81. PubMed ID: 10698003
[TBL] [Abstract][Full Text] [Related]
8. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum.
Giuffrida A; Parsons LH; Kerr TM; Rodríguez de Fonseca F; Navarro M; Piomelli D
Nat Neurosci; 1999 Apr; 2(4):358-63. PubMed ID: 10204543
[TBL] [Abstract][Full Text] [Related]
9. Acute effects of D1- and D2-receptor agonist and antagonist drugs on somatostatin binding, inhibition of adenylyl cyclase activity and accumulation of inositol 1,4,5-trisphosphate in the rat striatum.
Izquierdo-Claros RM; Boyano-Adánez MC; Larsson C; Gustavsson L; Arilla E
Brain Res Mol Brain Res; 1997 Jul; 47(1-2):99-107. PubMed ID: 9221906
[TBL] [Abstract][Full Text] [Related]
10. Lower efficacy of the dopamine D1 agonist, SKF 38393, to stimulate adenylyl cyclase activity in primate than in rodent striatum.
Pifl C; Reither H; Hornykiewicz O
Eur J Pharmacol; 1991 Sep; 202(2):273-6. PubMed ID: 1839386
[TBL] [Abstract][Full Text] [Related]
11. Selective blockade of a slowly inactivating potassium current in striatal neurons by (+/-) 6-chloro-APB hydrobromide (SKF82958).
Nisenbaum ES; Mermelstein PG; Wilson CJ; Surmeier DJ
Synapse; 1998 Jul; 29(3):213-24. PubMed ID: 9635891
[TBL] [Abstract][Full Text] [Related]
12. Dopamine D1 and D2 agonist effects on prepulse inhibition and locomotion: comparison of Sprague-Dawley rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J mice.
Ralph RJ; Caine SB
J Pharmacol Exp Ther; 2005 Feb; 312(2):733-41. PubMed ID: 15494551
[TBL] [Abstract][Full Text] [Related]
13. Expression and function of CB1 receptor in the rat striatum: localization and effects on D1 and D2 dopamine receptor-mediated motor behaviors.
Martín AB; Fernandez-Espejo E; Ferrer B; Gorriti MA; Bilbao A; Navarro M; Rodriguez de Fonseca F; Moratalla R
Neuropsychopharmacology; 2008 Jun; 33(7):1667-79. PubMed ID: 17957223
[TBL] [Abstract][Full Text] [Related]
14. Dopamine D1 receptors: efficacy of full (dihydrexidine) vs. partial (SKF38393) agonists in primates vs. rodents.
Watts VJ; Lawler CP; Gilmore JH; Southerland SB; Nichols DE; Mailman RB
Eur J Pharmacol; 1993 Sep; 242(2):165-72. PubMed ID: 7902811
[TBL] [Abstract][Full Text] [Related]
15. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
Hu XT; Brooderson RJ; White FJ
Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
[TBL] [Abstract][Full Text] [Related]
16. Forskolin potentiates the stimulation of rat striatal adenylate cyclase mediated by D-1 dopamine receptors, guanine nucleotides, and sodium fluoride.
Battaglia G; Norman AB; Hess EJ; Creese I
J Neurochem; 1986 Apr; 46(4):1180-5. PubMed ID: 3005508
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic behaviors and signal transduction mediated through adenylate cyclase and phospholipase C pathways.
Undie AS; Berki AC; Beardsley K
Neuropharmacology; 2000; 39(1):75-87. PubMed ID: 10665821
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a distinct D1-like dopamine receptor that couples to activation of phosphoinositide metabolism in brain.
Undie AS; Weinstock J; Sarau HM; Friedman E
J Neurochem; 1994 May; 62(5):2045-8. PubMed ID: 7908949
[TBL] [Abstract][Full Text] [Related]
19. Ventral striatal vs. accumbal (shell) mechanisms and non-cyclase-coupled dopamine D(1)-like receptors in jaw movements.
Hasegawa M; Adachi K; Nakamura S; Sato M; Waddington JL; Koshikawa N
Eur J Pharmacol; 2001 Jul; 423(2-3):171-8. PubMed ID: 11448482
[TBL] [Abstract][Full Text] [Related]
20. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
Pollack AE; Yates TM
Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
